Cite
HARVARD Citation
Szarvas, T. et al. (2016). Soluble syndecan‐1 (SDC1) serum level as an independent pre‐operative predictor of cancer‐specific survival in prostate cancer. Prostate. 76 (11), pp. 977-985. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Szarvas, T. et al. (2016). Soluble syndecan‐1 (SDC1) serum level as an independent pre‐operative predictor of cancer‐specific survival in prostate cancer. Prostate. 76 (11), pp. 977-985. [Online].